Details der Publikation - An MR-scan study of Liraglutide on cardiac function and cardiac blood flow in patients with type 2 diabetes and impaired filling of the heart.

An MR-scan study of Liraglutide on cardiac function and cardiac blood flow in patients with type 2 diabetes and impaired filling of the heart. : Influence of liraglutide on diastolic cardiac function and myocardial perfusion as determined by magnetic resonance imaging in patients with type 2 diabetes: a double-blind randomized parallel-group trial

Medienart:	Klinische Studie

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	WHO International Clinical Trials Registry Platform - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: Type 2 diabetes mellitus and diastolic heart faliure MedDRA version: 18.0Level: LLTClassification code 10069211Term: Diastolic heart failureSystem Organ Class: 100000004849 MedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] Phase: Phase 4 Recruitment Status: Not yet recruiting Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 30-06-2015, Last updated: 2023-06-29

ICTRP ID:	EUCTR2015-000410-22-DK U1111-1140-6242

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG004263278

Internformat


LEADER	01000caa a22002652 4500
001	CTG004263278
003	DE-627
005	20230629100623.0
007	cr uuu---uuuuu
008	210507s2023 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)CTG004263278
035			\|a (UBBS_Klinische_Studien_WHO)EUCTR2015-000410-22-DK
035			\|a (UBBS_Klinische_Studien_WHO)U1111-1140-6242
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a An MR-scan study of Liraglutide on cardiac function and cardiac blood flow in patients with type 2 diabetes and impaired filling of the heart. \|b Influence of liraglutide on diastolic cardiac function and myocardial perfusion as determined by magnetic resonance imaging in patients with type 2 diabetes: a double-blind randomized parallel-group trial
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 30-06-2015, Last updated: 2023-06-29
650		4	\|a Medical Condition: Type 2 diabetes mellitus and diastolic heart faliure MedDRA version: 18.0Level: LLTClassification code 10069211Term: Diastolic heart failureSystem Organ Class: 100000004849 MedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 4
650		4	\|a Recruitment Status: Not yet recruiting
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2023) vom: 21. Juni
773	1	8	\|g year:2023 \|g day:21 \|g month:06
856	4	0	\|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000410-22 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
951			\|a AR
952			\|j 2023 \|b 21 \|c 06

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände